
Sign up to save your podcasts
Or
Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
20 Listeners
48 Listeners
9 Listeners
35 Listeners
26 Listeners
18 Listeners
30 Listeners
134 Listeners
51 Listeners
2 Listeners
62 Listeners
21 Listeners
5 Listeners
14 Listeners
21 Listeners